InvestorsHub Logo
Followers 79
Posts 24524
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Thursday, 10/17/2019 8:13:14 AM

Thursday, October 17, 2019 8:13:14 AM

Post# of 27431
CANF - 2.32 Pre-market now at 4.75/4.90

Can-Fite and Gebro Pharma holding European Conference on Development & Commercialization of Phase III Drug Candidate Piclidenoson in the Treatment of Rheumatoid Arthritis

https://www.tradescores.com/StockReport/canf

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.